What is Zacks Research’s Forecast for CLB FY2025 Earnings?

Core Laboratories Inc. (NYSE:CLB) – Research analysts at Zacks Research lowered their FY2025 earnings per share estimates for shares of Core Laboratories in a research note issued to investors on Monday, June 16th. Zacks Research analyst R. Department now anticipates that the oil and gas company will post earnings per share of $0.70 for the year, down from their previous estimate of $0.71. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2026 earnings at $0.19 EPS, Q4 2026 earnings at $0.27 EPS, FY2026 earnings at $0.83 EPS and Q1 2027 earnings at $0.21 EPS.

A number of other equities analysts have also commented on the company. Stifel Nicolaus lowered their price objective on Core Laboratories from $19.00 to $15.00 and set a “hold” rating on the stock in a research note on Tuesday, April 15th. Citigroup lowered their price objective on Core Laboratories from $16.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 13th. Finally, Wall Street Zen lowered Core Laboratories from a “hold” rating to a “sell” rating in a research note on Friday, April 25th. Two analysts have rated the stock with a sell rating and three have assigned a hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $15.00.

Core Laboratories Stock Performance

NYSE:CLB opened at $12.71 on Tuesday. The stock has a 50 day simple moving average of $11.74 and a 200 day simple moving average of $15.10. Core Laboratories has a 1-year low of $10.14 and a 1-year high of $25.13. The company has a current ratio of 2.21, a quick ratio of 1.64 and a debt-to-equity ratio of 0.48. The stock has a market cap of $595.61 million, a P/E ratio of 21.53, a PEG ratio of 3.71 and a beta of 1.40.

Core Laboratories (NYSE:CLB) last released its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The firm had revenue of $123.59 million for the quarter, compared to analyst estimates of $125.09 million. Core Laboratories had a return on equity of 15.06% and a net margin of 5.41%. The business’s revenue for the quarter was down 4.7% on a year-over-year basis. During the same period in the previous year, the business posted $0.19 earnings per share.

Hedge Funds Weigh In On Core Laboratories

Several hedge funds and other institutional investors have recently modified their holdings of CLB. Ariel Investments LLC increased its stake in shares of Core Laboratories by 7.4% in the 1st quarter. Ariel Investments LLC now owns 10,342,025 shares of the oil and gas company’s stock valued at $155,027,000 after purchasing an additional 709,455 shares during the last quarter. Hotchkis & Wiley Capital Management LLC bought a new position in shares of Core Laboratories in the 1st quarter valued at $6,008,000. Raymond James Financial Inc. bought a new position in shares of Core Laboratories in the 4th quarter valued at $6,760,000. Fred Alger Management LLC increased its stake in shares of Core Laboratories by 32.4% in the 1st quarter. Fred Alger Management LLC now owns 736,853 shares of the oil and gas company’s stock valued at $11,045,000 after purchasing an additional 180,344 shares during the last quarter. Finally, Nuveen LLC bought a new position in shares of Core Laboratories in the 1st quarter valued at $2,573,000. Institutional investors own 97.81% of the company’s stock.

Core Laboratories Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th were paid a $0.01 dividend. The ex-dividend date was Monday, May 5th. This represents a $0.04 annualized dividend and a dividend yield of 0.31%. Core Laboratories’s payout ratio is 6.78%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.